Sargent Bickham Lagudis LLC Viatris Inc Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Viatris Inc stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 20,781 shares of VTRS stock, worth $273,893. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,781
Previous 20,852
0.34%
Holding current value
$273,893
Previous $177,000
30.51%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding VTRS
# of Institutions
1,087Shares Held
963MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.85 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.22 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$819 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$758 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$749 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $16B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...